within Pharmacolibrary.Drugs.ATC.M;

model M01AB06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 0.012166666666666666,
    adminDuration  = 600,
    adminMass      = 0.2,
    adminCount     = 1,
    Vd             = 0.013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Alclofenac is a non-steroidal anti-inflammatory drug (NSAID) that was developed for the treatment of pain and inflammation in musculoskeletal disorders, such as osteoarthritis and rheumatoid arthritis. It is structurally related to diclofenac. Alclofenac was previously marketed in some countries; however, it is no longer widely used or approved due to adverse effects and lack of relative efficacy compared to other NSAIDs.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical adult after oral administration, as no published clinical PK studies are available.</p><h4>References</h4><ol><li>R N Brogden, R C Heel, T M Speight, G S Avery,Alclofenac: a review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders.,Drugs,1977<a href='https://pubmed.ncbi.nlm.nih.gov/21068/'>https://pubmed.ncbi.nlm.nih.gov/21068/</a></li><li>R Testa, L Airoldi, R Latini,Pharmacokinetics and bioavailability of alclofenac and its lysine-salt after different route of administration in the rabbit.,Pharmacological research communications,1978<a href='https://pubmed.ncbi.nlm.nih.gov/25443/'>https://pubmed.ncbi.nlm.nih.gov/25443/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end M01AB06;
